Department of Pediatrics

Training

• Neonatal Pharmacotherapy Fellowship, The Women's Hospital of Greensboro, 2006 - 2008

Licensure and Board Certification

• 2006 - 2019NC, Pharmacist license
• 2008 - 2020MO, Pharmacist license
• 2017 - 2024Board Certified Pediatric Pharmacotherapy Specialist

Recent Publications view all (52)

Publication Co-Authors

Alexandra Lahart

Nathalie El Ters

Jason Newland, M.D., M.Ed.

Phillip I. Tarr, M.D.

David A. Hunstad, M.D.

Barbara B. Warner, M.D., MSc

Jennifer A Wambach, M.D.

Thomas Ferkol, M.D.

Zachary A. Vesoulis, MD MSCI

Amit M Mathur, M.D., M.R.C.P.

Alexis M. Elward, M.D., M.P.H.

Rakesh Rao, M.D.

Halana Whitehead, MD

Francis Sessions Cole, III, M.D.

Washington University has a long tradition of collaboration amongst colleagues.The faculty above have co-authored publications with Christopher McPherson

1. Whitehead HV, McPherson CC, Vesoulis ZA, Cohlan BA, Rao R, Warner BB, Cole FS. The Challenge of Risk Stratification of Infants Born Preterm in the Setting of Competing and Disparate Healthcare Outcomes. J Pediatr. 2020;223:194-196. PMID:32711746 
2. McPherson C, Miller SP, El-Dib M, Massaro AN, Inder TE. The influence of pain, agitation, and their management on the immature brain. Pediatr Res. 2020;88(2):168-175. PMCID:PMC7223850  PMID:31896130 
3. McPherson C, O'Mara K. Provision of Sedation and Treatment of Seizures During Neonatal Therapeutic Hypothermia. Neonatal Netw. 2020;39(4):227-235. PMID:32675319 
4. Vesoulis ZA, McPherson CC, Whitehead HV. Racial disparities in calculated risk for bronchopulmonary dysplasia: a dataset. Data Brief. 2020;30:105674. PMCID:PMC7248447  PMID:32478148 
5. McPherson CC. Neonatal Herpes Simplex Virus: The Long Road to Improved Outcomes. Neonatal Netw. 2020;39(2):92-98. PMID:32317339 
6. Greenberg JM, Poindexter BB, Shaw PA, Bellamy SL, Keller RL, Moore PE, McPherson C, Ryan RM. Respiratory medication use in extremely premature (<29 weeks) infants during initial NICU hospitalization: Results from the prematurity and respiratory outcomes program. Pediatr Pulmonol. 2020;55(2):360-368. PMID:31794157 
7. Meyers RS, Thackray J, Matson KL, McPherson C, Lubsch L, Hellinga RC, Hoff DS. Key Potentially Inappropriate Drugs in Pediatrics: The KIDs List. J Pediatr Pharmacol Ther. 2020;25(3):175-191. PMCID:PMC7134587  PMID:32265601 
8. Kolf MJ, McPherson CC, Kniska KS, Luecke CM, Lahart MA, Pineda JA. Early Post-traumatic Seizure Occurrence in Pediatric Patients Receiving Levetiracetam Prophylaxis With Severe Traumatic Brain Injury. J Pediatr Pharmacol Ther. 2020;25(3):241-245. PMCID:PMC7134584  PMID:32265608 
9. Liviskie CJ, Brennan CC, McPherson CC, Vesoulis ZA. Propranolol for the Treatment of Lymphatic Malformations in a Neonate - A Case Report and Review of Literature. J Pediatr Pharmacol Ther. 2020;25(2):155-162. PMCID:PMC7025746  PMID:32071591 
10. Rostas SE, McPherson C. Caffeine Therapy in Preterm Infants: The Dose (and Timing) Make the Medicine. Neonatal Netw. 2019;38(6):365-374. PMID:31712401 
11. Lahart AC, McPherson CC, Gerber JS, Warner BB, Lee BR, Newland JG. Application of an antibiotic spectrum index in the neonatal intensive care unit. Infect Control Hosp Epidemiol. 2019;40(10):1181-1183. doi:10.1017/ice.2019  PMID:31352907 
12. McPherson C. Pharmacotherapy for the Prevention of Bronchopulmonary Dysplasia: Can Anything Compete with Caffeine and Corticosteroids? Neonatal Netw. 2019;38(4):242-249. PMID:31470395 
13. Liviskie CJ, DeAvilla KM, Zeller BN, Najaf T, McPherson CC. Nicardipine for the Treatment of Neonatal Hypertension During Extracorporeal Membrane Oxygenation. Pediatr Cardiol. 2019;40(5):1041-1045. PMID:31065758 
14. Charron AC, Carl MA, Warner BB, Newland JG, McPherson CC. Determinants of Initial Antibiotic Duration in Very Low Birth Weight Neonates. Infect Dis Ther. 2019;8(2):209-217. doi:10.1007/s40121-019-0241-6  PMCID:PMC6522625  PMID:30825133 
15. Ryan RM, Keller RL, Poindexter BB, D'Angio CT, Shaw PA, Bellamy SL, Moore PE, McPherson C, Greenberg JM, PROP Investigators.. Respiratory Medications in Infants <29 Weeks during the First Year Postdischarge: The Prematurity and Respiratory Outcomes Program (PROP) Consortium. J Pediatr. 2019;208:148-155.e3. PMCID:PMC6486865  PMID:30857774 
16. Ryan RM, Feng R, Bazacliu C, Ferkol TW, Ren CL, Mariani TJ, Poindexter BB, Wang F, Moore PE, Prematurity and Respiratory Outcome Program (PROP) Investigators.. Black Race Is Associated with a Lower Risk of Bronchopulmonary Dysplasia. J Pediatr. 2019;207:130-135.e2. PMCID:PMC6458591  PMID:30612812 
17. McPherson C, Luecke CM, Liviskie CJ, Zeller BN, Vesoulis ZA. Acetaminophen Serum Concentrations in Infants Treated Intravenously for Patent Ductus Arteriosus. J Pediatr Pharmacol Ther. 2019;24(2):134-137. PMCID:PMC6478358  PMID:31019406 
18. Rostas SE, McPherson C. Intravenous Lipid Emulsions in Infants: Is Balanced Better? Neonatal Netw. 2019;38(1):39-45. PMID:30679255 
19. McPherson C. Premedication for Endotracheal Intubation in the Neonate. Neonatal Netw. 2018;37(4):238-247. PMID:30567922 
20. McPherson C, Wambach JA. Prevention and Treatment of Respiratory Distress Syndrome in Preterm Neonates. Neonatal Netw. 2018;37(3):169-177. PMID:29789058 
21. McPherson C, Liviskie C, Zeller B, Nelson MP, Newland JG. Antimicrobial Stewardship in Neonates: Challenges and Opportunities. Neonatal Netw. 2018;37(2):116-123. PMID:29615159 
22. McPherson C, Lee BR, Terrill C, Hersh AL, Gerber JS, Kronman MP, Newland JG. Characteristics of Pediatric Antimicrobial Stewardship Programs: Current Status of the Sharing Antimicrobial Reports for Pediatric Stewardship (SHARPS) Collaborative. Antibiotics (Basel). 2018;7(1). PMCID:PMC5872115  PMID:29370071 
23. Rostas SE, McPherson C. Acid Suppression for Gastroesophageal Reflux Disease in Infants. Neonatal Netw. 2018;37(1):33-41. PMID:29436357 
24. Luecke CM, Liviskie CJ, Zeller BN, Vesoulis ZA, McPherson C. Acetaminophen for Patent Ductus Arteriosus in Extremely Low-Birth-Weight Neonates. J Pediatr Pharmacol Ther. 2017;22(6):461-466. PMCID:PMC5736259  PMID:29290747 
25. McPherson C, Inder T. Perinatal and neonatal use of sedation and analgesia. Semin Fetal Neonatal Med. 2017;22(5):314-320. PMID:28734732 
26. Liviskie CJ, Lange SA, McPherson CC. Precipitation of Heparin Products With Calcium Gluconate: The Activity of Inactive Ingredients. J Pediatr Pharmacol Ther. 2017;22(4):314-315. PMCID:PMC5562213  PMID:28943828 
27. Vesoulis ZA, Hao J, McPherson C, El Ters NM, Mathur AM. Low-frequency blood pressure oscillations and inotrope treatment failure in premature infants. J Appl Physiol (1985). 2017;123(1):55-61. PMCID:PMC6157481  PMID:28428252 
28. Luecke C, McPherson C. Treatment of Persistent Pulmonary Hypertension of the Newborn: Use of Pulmonary Vasodilators in Term Neonates. Neonatal Netw. 2017;36(3):160-168. PMID:28494828 
29. McPherson C, Smith JR. Analgesia in the Premature Neonate: Walking the Tightrope Requires a Great Team. J Perinat Neonatal Nurs. 2017;31(2):99-100. PMID:28437299 
30. Kalish BT. Management of Neonatal Hypotension. Neonatal Netw. 2017;36(1):40-47. PMID:28137353 
31. Rostas SE, McPherson C. Pharmacist-driven respiratory syncytial virus prophylaxis stewardship service in a neonatal intensive care unit. Am J Health Syst Pharm. 2016;73(24):2089-2094. PMID:27919877 
32. McPherson C. Morphine exposure in preterm infants correlates with impaired cerebellar growth and poorer neurodevelopmental outcome. Evid Based Med. 2016;21(6):234. PMID:27760778 
33. Vesoulis ZA, McPherson C, Neil JJ, Mathur AM, Inder TE. Early High-Dose Caffeine Increases Seizure Burden in Extremely Preterm Neonates: A Preliminary Study. J Caffeine Res. 2016;6(3):101-107. PMCID:PMC5031091  PMID:27679737 
34. Rostas SE, McPherson C. Systemic Corticosteroids for the Prevention of Bronchopulmonary Dysplasia: Picking the Right Drug for the Right Baby. Neonatal Netw. 2016;35(4):234-9. PMID:27461202 
35. Rostas SE, McPherson CC. Pharmacotherapy for Patent Ductus Arteriosus: Current Options and Outstanding Questions. Curr Pediatr Rev. 2016;12(2):110-9. PMID:27197952 
36. McPherson C. Pharmacotherapy for Neonatal Abstinence Syndrome: Choosing the Right Opioid or No Opioid at All. Neonatal Netw. 2016;35(5):314-20. PMID:27636696 
37. McPherson C, Haslam M, Pineda R, Rogers C, Neil JJ, Inder TE. Brain Injury and Development in Preterm Infants Exposed to Fentanyl. Ann Pharmacother. 2015;49(12):1291-7. PMCID:PMC4644677  PMID:26369570 
38. McPherson C, Neil JJ, Tjoeng TH, Pineda R, Inder TE. A pilot randomized trial of high-dose caffeine therapy in preterm infants. Pediatr Res. 2015;78(2):198-204. PMCID:PMC4928641  PMID:25856169 
39. Steinhorn R, McPherson C, Anderson PJ, Neil J, Doyle LW, Inder T. Neonatal morphine exposure in very preterm infants-cerebral development and outcomes. J Pediatr. 2015;166(5):1200-1207.e4. PMCID:PMC4928575  PMID:25919729 
40. Ruoss JL, McPherson C, DiNardo J.. Inotrope and vasopressor support in neonates. NeoReviews. 2015;16:e351-e361. 
41. McPherson C, Grunau RE. Neonatal pain control and neurologic effects of anesthetics and sedatives in preterm infants. Clin Perinatol. 2014;41(1):209-27. PMCID:PMC3925313  PMID:24524456 
42. McPherson C, Yaroslaski AM, Luedtke S, Super J.. Probiotic use in the NICCU: What's taking so long? Infant Child Adolesc Nutr. 2014;6:270-272. 
43. Heble DE Jr, McPherson C, Nelson MP, Hunstad DA. Vancomycin trough concentrations in overweight or obese pediatric patients. Pharmacotherapy. 2013;33(12):1273-7. PMID:23798327 
44. McPherson C. Sedation and analgesia in mechanically ventilated preterm neonates: continue standard of care or experiment? J Pediatr Pharmacol Ther. 2012;17(4):351-64. PMCID:PMC3567888  PMID:23413121 
45. McPherson C, Warner B, Hunstad DA, Elward A, Acosta EP. Oseltamivir dosing in premature infants. J Infect Dis. 2012;206(6):847-50. PMCID:PMC3572879  PMID:22807525 
46. Rao R, Bryowsky K, Mao J, Bunton D, McPherson C, Mathur A. Gastrointestinal complications associated with ibuprofen therapy for patent ductus arteriosus. J Perinatol. 2011;31(7):465-70. PMID:21252965 
47. Wilkerson J, McPherson C, Donze A. Fluconazole to prevent systemic fungal infections in infants: reviewing the evidence. Neonatal Netw. 2010;29(5):323-33. PMID:20829180 
48. McPherson C, Gal P, Ransom JL, Carlos RQ, Dimaguila MA, Smith M, Davonzo C, Wimmer JE Jr. Indomethacin pharmacodynamics are altered by surfactant: a possible challenge to current indomethacin dosing guidelines created before surfactant availability. Pediatr Cardiol. 2010;31(4):505-10. PMID:20063159 
49. McPherson C, Gal P, Smith M, Wilder W, Richter S, Ransom JL, Carlos RQ, Dimaguila MA, Wimmer Jr. JE.. Necrotizing enterocolitis in preterm infants with patent ductus arteriosus: does indomethacin increase the risk? Journal of Neonatal-Perinatal Medicine. 2008;1(4):209-216. 
50. McPherson C, Gal P, Ransom JL. Treatment of Citrobacter koseri infection with ciprofloxacin and cefotaxime in a preterm infant. Ann Pharmacother. 2008;42(7):1134-8. PMID:18577764 
51. Sykes R, McPherson C, Foulks K, Wade J, Gal P. Aminophylline compatibility with neonatal total parenteral nutrition. J Pediatr Pharmacol Ther. 2008;13(2):76-9. PMCID:PMC3462061  PMID:23055868 
52. Gura K, Strijbosch R, Arnold S, McPherson C, Puder M. The role of an intravenous fat emulsion composed of fish oil in a parenteral nutrition-dependent patient with hypertriglyceridemia. Nutr Clin Pract. 2007;22(6):664-72. PMID:18042955